Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Nuvo Research Inc.
During this 12-week study, patients will visit the study clinic 5 times. At the screening visit, the patient's demographic information, medical and medication history will be recorded and a physical examination performed. After washout of all NSAIDs/other analgesic medication, the patient will return for the baseline visit. During the treatment phase of the study, the patient will apply a topical solution to his/her osteoarthritic knee and take an oral study tablet. The patient may randomly receive active treatment with topical diclofenac, oral diclofenac, both, or neither (placebo). Follow-up clinic visits are conducted at 4, 8 and 12 weeks. Routine laboratory analyses are done at baseline, 4 and 12 weeks.
Age
40–85
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Primary osteoarthritis of the knee, verified radiographically
Moderate flare of pain in the knee after washout of stable therapy
If female, non-pregnant
Ability to swallow moderately-sized tablets
You may not be if
Secondary osteoarthritis of the knee
Major knee surgery at any time, or minor knee surgery in previous year
Severe uncontrolled heart, liver or kidney disease